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Abstract Brown adipose tissue (BAT) and skeletal muscle are 
important sites of nonshivering thermogenesis. The uncoupling 
protein-1 (UCP1) is the main effector of nonshivering thermo-
genesis in BAT and the recently described ubiquitous UCP2 [X] 
has been implicated in energy balance. In an attempt to better 
understand the biochemical events underlying nonshivering 
thermogenesis in muscle, we screened a human skeletal muscle 
cDNA library and isolated three clones: UCP2, UCP3L and 
UCP3S. The novel UCP3 was 57% and 73% identical to human 
UCP1 and UCP2, respectively, highly skeletal muscle-specific 
and its expression was unaffected by cold acclimation. This new 
member of the UCP family is a candidate protein for the 
modulation of the respiratory control in skeletal muscle. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The uncoupling protein-1 (UCP1) gene encodes a unique 
mammalian mitochondrial proton carrier that induces heat 
production in brown adipose tissue (BAT) by uncoupling res-
piration from ATP synthesis [for review, see [2]]. Despite its 
tissue specificity, UCP1 is a member of the mitochondrial 
carrier protein family, which includes the ATP/ADP translo-
cator, the phosphate, the 2-oxoglutarate/malate and the cit-
rate (tricarboxylate) carriers [for review, see [3]]. Human 
UCP1 gene, located in 4q31, is made up of six exons and 
encodes a 307-amino-acid sequence with no targeting prese-
quence [4]. Like other mitochondrial carriers, UCP1 is in-
serted into the inner mitochondrial membrane by means of 
6 ot-helical hydrophobic domains, each encoded by one of the 
six exons [5]. Its polypeptide chains consist of three tandemly 
related sequences of about 100 amino acids, each encoded by 
two exons and corresponding to two transmembrane domains 
[6]. Topological studies suggest that both the C- and N-termi-
nal ends of UCP1 are oriented towards the cytosolic side of 
the inner mitochondrial membrane [7]. 
Structure-function studies have been performed on UCP1 
and a putative purine nucleotide binding domain, analogous 
to that observed in the ATP/ADP carrier, has been described, 
which is located between amino acids 273 and 295 [8] in rat 
UCP1 (SWISS-PROT P04633). It has been suggested that 
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cysteine-302 participates in the modulation of UCP1 activity 
by fatty acids [9] and that amino acids 13-105 are necessary 
for the targeting and insertion of UCP1 into the mitochon-
drial inner membrane [10]. Conserved residues, characteristic 
of the mitochondrial carrier proteins, have been described: 
their presence at the borders of transmembrane domains 1, 
3 and 5 is characteristic of all members of this family and they 
are referred to as mitochondrial energy-transfer-protein signa-
tures [11]. 
Contrary to the ATP/ADP translocator, which is a more 
elementary carrier, UCP1 is highly regulated [12]. Its activity 
is decreased by purine nucleotides di- or triphosphates and 
increased by fatty acids [2]. 
BAT is an important effector of nonshivering thermogenesis 
in rodents [2]. In humans, BAT expressing UCP1 is found in 
the newborn; it decreases during infancy but is still detected in 
the adult [13]. Under physiological conditions, BAT does not 
play a significant role in nonshivering thermogenesis in adult 
humans. 
Very recently a novel member of the UCP family (UCP2) 
has been described [1]. This protein, which is widely expressed 
in human tissues, might play a role in energy balance. 
Skeletal muscle contributes for up to 40% of whole-body 
epinephrine-induced thermogenesis in humans [14]. In the rat, 
in vivo administration of the ß3-adrenoceptor agonist BRL 
28410 was found to stimulate skeletal muscle heat production 
[15] and recently, Nagase et al. [16] reported that a chronic 
treatment of obese yellow KK mice with the ß3-adrenoceptor 
agonist CL 316,243 induced ectopic expression of UCP1 in 
the skeletal muscle. Therefore, epinephrine-induced thermo-
genesis in human skeletal muscle [14] might be mediated by 
a skeletal muscle UCP. 
In search for UCP homologues in human skeletal muscle, 
we screened a skeletal muscle cDNA library and isolated three 
cDNA clones: UCP2, UCP3L and UCP3S. Whereas UCP2 
mRNA was found in all tissues studied, as shown by Fleury 
et al. [1], UCP3 was highly skeletal muscle-specific. These new 
members of the UCP family are candidate proteins for the 
modulation of tissue respiratory control, with UCP3 being 
highly specific for skeletal muscle. 
2. Materials and methods 
2.1. Library screening 
Total RNA from rat tibialis anterior muscle and interscapular BAT 
were purified by the method of Chomczynski and Sacci [17], and 
amplified by reverse transcription-polymerase chain reaction using 
primers corresponding to conserved domains of rat UCP1, i.e. in 
positions 279-298 (UCPRF) and 1021-1044 (UCPRR) on GenBank 
Accession Ml 1814. Single fragments of similar size were obtained 
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from both tissues. The BAT PCR product's sequence was identical to 
that of the rat UCPl cDNA, whereas that from the tibialis anterior 
muscle was different, bearing ca. 60% identity to rat UCPl. This 
cDNA, referred to as rat atypical UCP cDNA, was used as a probe 
to screen a human skeletal muscle cDNA library (Stratagene, 
#936215, La Jolla, CA). 
2.2. Clone sequencing 
cDNA clones were purified by Qiagen plasmid kit according to the 
manufacturer's instructions (Quiagen, Santa Clarita, CA) and se-
quenced using standard protocols for the ABI373A automated se-
quencer with the Ml3-20 and T3 primers and gene-specific primers 
until the sequence was determined on both strands. 
2.3. Human tissue samples 
The human Multiple Tissue Northern blot (#7760-1) was from 
Clontech Laboratories Inc. (Palo Alto, CA). Pieces of human omental 
white adipose (10-40 g) or abdominal skeletal muscle (800 mg) were 
obtained during intra-abdominal surgery. Pieces of pedreñal brown 
adipose tissue weighing about 1.5 g were obtained during renal sur-
gery from infants (mean age: 3 months). The project has been ap-
proved by the Ethics Commission of the Department of Surgery, 
Faculty of Medicine, University of Geneva. 
2.4. Rat treatment and tissue samples 
Seven-week-old Sprague-Dawley male rats fed ad libitum standard 
laboratory chow were caged individually with a 12-h light-dark cycle. 
Cold adaptation was performed at 6°C for 20 days during which the 
rats were pair-fed to control rats kept at 23°C. They were killed by 
cervical dislocation. All experiments were performed in accordance 
with our institutional guidelines. 
2.5. Northern analysis 
Total RNA (12-20 \i%) was electrophoresed in a 1.2% agarose gel 
containing formaldehyde, as described by Lehrach et al. [18] and 
transferred to Electran Nylon Blotting membranes (BDH Laboratory 
Supplies, Poole, UK) by vacuum blotting. Probes were labeled by 
random priming with [a-32P]dCTP (Amersham, Bucks, UK) to a spe-
cific radioactivity of approximately 1 X 109 dpm^g DNA. RNA blots 
were hybridized for 2 h at 65°C in QuikHyb (Stratagene, La Jolla, 
CA), then washed in a solution of 2 X SSC (1X SSC is 150 mM NaCl, 
15 mM sodium citrate, pH 7.0)/0.1% sodium dodecyl sulfate (SDS) at 
50°C twice for 5 min and in 0.1 XSSC/0.1% SDS at 50°C for 5 min. 
Blots were exposed to Hyperfilm ECL films (Amersham, Bucks, UK) 
at — 80°C with intensifying screens. Size estimates for the RNA species 
were established by comparison with an RNA Ladder (Gibco BRL, 
New York, NY). The signals on the autoradiograms were quantified 
by scanning photodensitometry using ImageQuant Software Version 
3.3 (Molecular Dynamics). Hybridization of the blots with a [γ-
32P]ATP-labeled synthetic oligonucleotide specific for the 18S rRNA 
subunit was used to correct for differences in the amounts of RNA 
loaded onto the gel. 
3. Results and discussion 
Screening of ca. 1000 000 phages from the human skeletal 
muscle c D N A library with a rat atypical U C P c D N A probe 
(see Section 2) resulted in the isolation of 10 positive clones. 
Among them, three different categories were found by se-
quencing. The predicted polypeptides of these three clones 
which contain 309, 312 and 275 amino acids are illustrated 
in Fig. 1. The 309-amino-acid protein is U C P 2 recently iso-
lated by Fleury et al. [1]. The two other proteins have their 
first 275 amino acids in common, suggesting that they are 
isoforms. They have amino acid identities of 57% and 73% 
to human U C P l and UCP2, respectively and, as such, are 
considered as novel proteins referred to as UCP3 long and 
short forms, U C P 3 L and UCP3s , respectively (GenBank Ac-
cessions U84763 and U82818). Like other mitochondrial car-
riers, U C P 2 and U C P 3 L contain six predicted t ransmembrane 
domains (Fig. 1). Potential purine nucleotide binding domains 
extend between amino acid residues 276-298 in U C P 2 and 
279-301 in U C P 3 L . U C P 3 S lacks the sixth potential trans-
membrane region and the purine nucleotide binding domain 
implicated in the control of the coupling efficiency of U C P l 
[8]. Binding of guanosine diphosphate (GDP) to U C P l is 
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Fig. 1. Amino acid sequence alignments of human UCP3L, UCP3S, UCP2 (GenBank Accession U82819) and UCPl (UCP) obtained with the 
ClustalW Multiple Sequence Alignment program (K.C. Worley, Human Genome Center, Baylor College of Medicine). The sequences are pre-
sented in single letter code. Gaps introduced into the sequences to optimize alignments are illustrated with a dash. Identical and similar amino 
acids are highlighted in red and blue, respectively. Potential transmembrane a-helices are underlined and numbered in roman numerals (I-VI). 
The potential purine-nucleotide binding domain (PNBD) is underlined twice. The three mitochondrial energy-transfer-protein signature domains 
are boxed. The 14-amino-acid residues which are totally conserved in mitochondrial carrier proteins are shown with asterisks. 
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Fig. 2. Expression of UCP2 and UCP3 in human and rat tissues. 
A: Autoradiogram of a Northern blot of various human tissue pol-
y(A) RNA hybridized with a 32P-labeled human UCP2 probe con-
sisting of the full-length UCP2 cDNA. The molecular size markers 
are indicated in kb. Inset: UCP2 expression in total RNA. Brown 
adipose tissue (BAT); white adipose tissue (WAT). B: Autoradio-
gram of a Northern blot of various human tissue poly(A) RNA hy-
bridized with a 32P-labeled human UCP3 probe consisting of the 
full-length UCP3S cDNA. Inset: UCP3 expression in total RNA. 
C: Autoradiogram of a Northern blot of various rat tissue total 
RNA. The 32P-labeled rat atypical UCP cDNA probe used (see Sec-
tion 2) hybridized to the rat 3 UCP species, i.e. UCP1 (1.4 kb), 
UCP2 (1.7 kb) and UCP3 (2.5 and 2.8 kb). 
known to induce a conformational change leading to inhib-
ition of H + and Cl permeability [2]. Therefore, UCP3g 
would exert its biological effect without any control by 
GDP. As also illustrated in Fig. 1, other structural features 
of mitochondrial carriers are observed in UCP2 as well as in 
U C P 3 L and UCP3s: the three mitochondrial energy-transfer-
protein signatures [11], which can be identified at the border 
and downstream of the first, third and fifth potential trans-
membrane domains, and the 14 conserved mitochondrial car-
rier residues [3]. 
UCP2 and UCP3 have the highest predicted amino acid 
sequence homology to UCP1 as compared to the other mem-
bers of the mitochondrial carrier protein family. Indeed, their 
identities to UCP1 are of 55% and of 56%, respectively, 
whereas those to the most closely related mitochondrial car-
rier protein 2-oxoglutarate/malate carrier are of 32%. UCP2 
and UCP3 should therefore belong to the UCP family. In-
deed, Fleury et al. [1] showed that UCP2 has uncoupling 
properties when expressed in yeast. 
Human tissue UCP2 and UCP3 distributions were then 
compared by Northern blot analyses. As shown in Fig. 2A 
and in the inset, an UCP2 signal at a size of 1.7 kb was 
observed in all human tissues studied. UCP2 was expressed 
at the highest level in BAT > white adipose tissue > skeletal 
muscle. By contrast, UCP3 expression (2.3 kb signal) was 
restricted to skeletal muscle and heart, though it was much 
lower in the latter (Fig. 2B and inset). Direct comparison of 
the Northern blots hybridized with UCP2 and UCP3 probes 
showed that UCP3 was much more expressed in skeletal 
muscle than UCP2 in any of the tissues studied. Specific 
probes for the long or short form of UCP3 revealed that 
the two forms gave the same signal at 2.3 kb, and quantifica-
tion of the signal intensity showed that both forms are ex-
pressed at similar levels in human skeletal muscle (results not 
shown). 
The tissue distribution of UCP2 and UCP3 mRNAs was 
also studied in the rat using the rat atypical UCP cDNA 
probe, which hybridizes to the rat 3 UCP species, i.e. 
UCP1, UCP2 and UCP3. As shown in Fig. 2C, UCP2 was 
expressed in all tissues studied: heart > BAT > white adipose 
tissue > skeletal muscle. A major difference as compared to 
human UCP2 is its high degree of expression in the heart. 
UCP3 was most highly expressed in BAT, at a high level in 
tensor fascia latae (fast-twitch glycolytic), tibialis anterior 
(fast-twitch oxidative-glycolytic), gastrocnemius (mixed) 
muscles and less in soleus muscle (slow-twitch oxidative). 
This suggests that UCP3 is more expressed in glycolytic 
than in oxidative skeletal muscles. UCP3 was also detected, 
although at a much lower level, in rat heart and kidney, and 
occasionally in white adipose tissue. It has been shown in 
rodents but not in humans that UCP1 mRNA signal exists 
in two sizes [1]. It can be seen in Fig. 2C that UCP3 signal is a 
doublet whereas UCP2 signal is single. The sizes of the sig-
nals, as compared to an RNA ladder, were of 1.4 and 1.8 kb 
for UCP1, 1.7 kb for UCP2, and 2.5 and 2.8 kb for UCP3. 
Altogether, the results show that the tissue distributions of 
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U C P 2 and U C P 3 are very different from that of U C P 1 , i.e. 
either ubiquitous or, in humans, highly specific to skeletal 
muscle, respectively. 
UCP2 and UCP3 expressions were studied in the tibialis 
anterior muscle of rats acclimated to cold, a condition known 
to strongly increase UCP1 in BAT [2]. It was found that 20 
days of cold adaptat ion had no effect on UCP2 and U C P 3 
expressions in tibialis anterior (results not shown). This sug-
gests that skeletal muscle U C P 2 and UCP3 are differentially 
regulated from BAT U C P 1 . 
The present study describes new members of the U C P fam-
ily and provides evidence for candidate genes possibly in-
volved in the uncoupling of oxidative phosphorylation specif-
ically in skeletal muscle, an important site of nonshivering 
thermogenesis in humans. A n understanding of the molecular 
and biochemical basis of skeletal muscle thermogenesis will 
have wide implications for both basic and clinical research 
in metabolic regulation in general, and in the areas of obesity 
and cachexia in particular. 
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